483 Aurobindo Pharma Limited Unit-VIII Oct 2019

483 Aurobindo Pharma Limited Unit-VIII Oct 2019

Gayle Lawson FDA, Kenneth Williams FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma Limited Unit-VIII - Sangareddy District, India facility and issued inspectional observations (via FDA 483) on 25 Oct 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Oct 2019
  • Location: Sangareddy District, India
  • FEI: 3004086884
Add To Cart